• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPP1、PAI和小窝蛋白-1在口腔鳞状细胞癌患者中的预后和预测价值。

Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.

作者信息

Huang Cong-Fa, Yu Guang-Tao, Wang Wei-Ming, Liu Bing, Sun Zhi-Jun

机构信息

The State Key Laboratory Breeding Base of Basic Science of Stomatology & Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University Wuhan, China.

The State Key Laboratory Breeding Base of Basic Science of Stomatology & Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University Wuhan, China ; Department of Oral Maxillofacial-Head Neck Oncology, School and Hospital of Stomatology, Wuhan University Wuhan, China.

出版信息

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6032-9. eCollection 2014.

PMID:25337248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4203219/
Abstract

SPP1, PAI and caveolin-1 are known to be closely associated with tumor progression in several kinds of human tumors. This study aimed to investigate the expression of SPP1, PAI and caveolin-1 in oral squamous cell carcinoma (OSCC), and to evaluate their association with the prognosis in oral carcinoma. Immunohistochemical staining was used to examine the expression of SPP1, PAI and caveolin-1 in 17 normal oral mucosa, 6 oral epithelial dysplasia and 43 OSCC specimens by tissue microarrays. High expression of SPP1, PAI and caveolin-1 was found in OSCC patients, and SPP1 and PAI expression were significantly higher in OSCC than in normal oral mucosa. No significant correlations were found between SPP1, PAI and caveolin-1 expression and clinicopathological factors. Expression of SPP1, PAI and caveolin-1 was also not associated with overall survival. Moreover, SPP1 was closely correlated with PAI, caveolin-1 and Keap1, and PAI had significant correlations with caveolin-1, Keap1 and Nrf2, and caveolin-1 was associated with Keap1 by using the Pearson correlation coefficient test. Our findings suggest that overexpressed SPP1, PAI and caveolin-1 were linked to carcinogenesis and progression, and thus they may serve as potential prognostic factors in OSCC.

摘要

已知分泌性磷蛋白1(SPP1)、纤溶酶原激活物抑制剂(PAI)和小窝蛋白-1(caveolin-1)与多种人类肿瘤的进展密切相关。本研究旨在调查SPP1、PAI和caveolin-1在口腔鳞状细胞癌(OSCC)中的表达情况,并评估它们与口腔癌预后的相关性。采用免疫组织化学染色法,通过组织芯片检测17例正常口腔黏膜、6例口腔上皮发育异常和43例OSCC标本中SPP1、PAI和caveolin-1的表达。在OSCC患者中发现SPP1、PAI和caveolin-1高表达,且OSCC中SPP1和PAI的表达显著高于正常口腔黏膜。未发现SPP1、PAI和caveolin-1的表达与临床病理因素之间存在显著相关性。SPP1、PAI和caveolin-1的表达也与总生存期无关。此外,使用Pearson相关系数检验发现,SPP1与PAI、caveolin-1和 Kelch样环氧氯丙烷相关蛋白1(Keap1)密切相关,PAI与caveolin-1、Keap1和核因子E2相关因子2(Nrf2)显著相关,caveolin-1与Keap1相关。我们的研究结果表明,SPP1、PAI和caveolin-1的过表达与致癌作用和肿瘤进展有关,因此它们可能作为OSCC潜在的预后因素。

相似文献

1
Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.SPP1、PAI和小窝蛋白-1在口腔鳞状细胞癌患者中的预后和预测价值。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6032-9. eCollection 2014.
2
Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.小窝蛋白-1在口腔扁平苔藓、发育异常病变及鳞状细胞癌中的表达
Pathol Res Pract. 2017 Jul;213(7):809-814. doi: 10.1016/j.prp.2017.03.006. Epub 2017 Mar 9.
3
FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.FLOT-2是口腔鳞状细胞癌中的一个独立预后标志物。
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8236-43. eCollection 2015.
4
Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.含锌指 AN1 结构域蛋白 4 是预测口腔鳞状细胞癌转移和预后不良的新型标志物。
J Clin Pathol. 2018 May;71(5):436-441. doi: 10.1136/jclinpath-2017-204770. Epub 2017 Oct 26.
5
Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma.Keap1 和 Nrf2 在口腔鳞状细胞癌中的临床意义。
PLoS One. 2013 Dec 27;8(12):e83479. doi: 10.1371/journal.pone.0083479. eCollection 2013.
6
Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.智利人群口腔和口咽鳞状细胞癌的临床病理及免疫组化评估
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5968-77. eCollection 2014.
7
Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.Nrf2、Keap1、p16和E-钙黏蛋白表达在卵巢上皮癌中的预后及预测价值
Int J Clin Exp Pathol. 2015 May 1;8(5):5642-9. eCollection 2015.
8
High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.TROP2的高表达与口腔鳞状细胞癌的不良预后相关。
Pathol Res Pract. 2018 Oct;214(10):1606-1612. doi: 10.1016/j.prp.2018.07.017. Epub 2018 Jul 25.
9
The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.口腔鳞状细胞癌中5-羟甲基胞嘧啶的水平及临床意义:95例患者的免疫组织化学研究
Pathol Res Pract. 2017 Aug;213(8):969-974. doi: 10.1016/j.prp.2017.04.016. Epub 2017 Apr 19.
10
[Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].[尿激酶型纤溶酶原激活剂(uPA)与纤溶酶原激活剂抑制剂(PAI-1)在口腔鳞状细胞癌原发切除术中的比较]
Mund Kiefer Gesichtschir. 2004 May;8(3):180-90. doi: 10.1007/s10006-003-0519-3. Epub 2004 Feb 6.

引用本文的文献

1
Investigating the potential role of EIF2S2 in OSCC progression through comprehensive bioinformatics analysis and experimental validation.通过全面的生物信息学分析和实验验证来研究真核生物翻译起始因子2亚基2(EIF2S2)在口腔鳞状细胞癌(OSCC)进展中的潜在作用。
Eur J Med Res. 2025 Jul 2;30(1):562. doi: 10.1186/s40001-025-02830-x.
2
Identification of diagnostic biomarkers and immune cell infiltration in tongue squamous cell carcinoma using bioinformatic approaches.使用生物信息学方法鉴定舌鳞状细胞癌的诊断生物标志物和免疫细胞浸润。
Eur J Med Res. 2024 Aug 21;29(1):428. doi: 10.1186/s40001-024-01998-y.
3
Mechanisms and markers of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维化恶性转化的机制与标志物
Heliyon. 2023 Dec 7;10(1):e23314. doi: 10.1016/j.heliyon.2023.e23314. eCollection 2024 Jan 15.
4
Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.鉴定食管鳞癌中 TREM2 阳性肿瘤相关巨噬细胞:对预后不良和免疫治疗调节的意义。
Front Immunol. 2023 Apr 28;14:1162032. doi: 10.3389/fimmu.2023.1162032. eCollection 2023.
5
Construction and analysis of a conjunctive diagnostic model of HNSCC with random forest and artificial neural network.基于随机森林和人工神经网络构建并分析头颈部鳞状细胞癌联合诊断模型。
Sci Rep. 2023 Apr 25;13(1):6736. doi: 10.1038/s41598-023-32620-6.
6
Cholesterol Is a Regulator of CAV1 Localization and Cell Migration in Oral Squamous Cell Carcinoma.胆固醇是口腔鳞状细胞癌中 Cav1 定位和细胞迁移的调节剂。
Int J Mol Sci. 2023 Mar 23;24(7):6035. doi: 10.3390/ijms24076035.
7
Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes.通过鉴定和抑制个体化癌症进程克服头颈部鳞状细胞癌对 EGFR 单药治疗的抵抗。
Theranostics. 2022 Jan 1;12(3):1204-1219. doi: 10.7150/thno.64347. eCollection 2022.
8
Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.单细胞RNA测序揭示非小细胞肺癌中肿瘤相关巨噬细胞的异质性及性别差异。
Front Immunol. 2021 Nov 5;12:756722. doi: 10.3389/fimmu.2021.756722. eCollection 2021.
9
SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma.SPP1和FN1是舌鳞状细胞癌的重要基因生物标志物。
Oncol Lett. 2021 Oct;22(4):713. doi: 10.3892/ol.2021.12974. Epub 2021 Aug 6.
10
Upregulation of Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance.的上调是肺癌预后不良的标志物,并促进癌症进展和顺铂耐药。 (注:原文中“Upregulation of ”后面缺少具体内容)
Front Cell Dev Biol. 2021 Apr 29;9:646390. doi: 10.3389/fcell.2021.646390. eCollection 2021.

本文引用的文献

1
Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma.Keap1 和 Nrf2 在口腔鳞状细胞癌中的临床意义。
PLoS One. 2013 Dec 27;8(12):e83479. doi: 10.1371/journal.pone.0083479. eCollection 2013.
2
Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.靶向纤溶酶原激活物抑制剂-1 抑制人肿瘤异种移植模型中的血管生成和肿瘤生长。
Mol Cancer Ther. 2013 Dec;12(12):2697-708. doi: 10.1158/1535-7163.MCT-13-0500. Epub 2013 Sep 26.
3
Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance.肝癌缺失基因1和纤溶酶原激活物抑制剂1蛋白在卵巢癌中的表达及其临床意义。
J Exp Clin Cancer Res. 2013 Aug 30;32(1):60. doi: 10.1186/1756-9966-32-60.
4
Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.基质的分子谱分析鉴定骨桥蛋白为肝内胆管癌不良预后的独立预测因子。
Hepatology. 2013 Dec;58(6):1992-2000. doi: 10.1002/hep.26577. Epub 2013 Oct 17.
5
Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.尿激酶型纤溶酶原激活物及其抑制剂-1 在卵巢癌中的表达及其临床意义。
Oncol Rep. 2013 Feb;29(2):637-45. doi: 10.3892/or.2012.2148. Epub 2012 Nov 20.
6
Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.骨桥蛋白增加血红素加氧酶-1 的表达,进而诱导胶质瘤细胞的迁移和侵袭。
Neuro Oncol. 2012 Nov;14(11):1367-78. doi: 10.1093/neuonc/nos262. Epub 2012 Oct 16.
7
Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.NRF2 和 Sulfiredoxin 的遗传多态性和蛋白表达可预测乳腺癌的生存结局。
Cancer Res. 2012 Nov 1;72(21):5537-46. doi: 10.1158/0008-5472.CAN-12-1474. Epub 2012 Sep 10.
8
Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.mTOR 抑制剂在遗传定义的头颈部鳞状细胞癌小鼠模型中的化学预防和化学治疗作用。
Clin Cancer Res. 2012 Oct 1;18(19):5304-13. doi: 10.1158/1078-0432.CCR-12-1371. Epub 2012 Aug 2.
9
Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.TROG 02.02 三期临床试验中局部晚期头颈部鳞状细胞癌患者血浆骨桥蛋白的预后意义。
Clin Cancer Res. 2012 Jan 1;18(1):301-7. doi: 10.1158/1078-0432.CCR-11-2295. Epub 2011 Nov 17.
10
An in vivo platform for tumor biomarker assessment.一种用于肿瘤生物标志物评估的体内平台。
PLoS One. 2011;6(10):e26722. doi: 10.1371/journal.pone.0026722. Epub 2011 Oct 26.